Who should be accountable for approving GenAI use in development workflows?

Who owns GenAI approval in a development workflow?

Approval for GenAI use should be owned by the leaders who can set guardrails, accept residual risk, and enforce review discipline across the development lifecycle. That usually means application security, security engineering, and the product or engineering leader accountable for the delivery environment. Individual developers can propose tools and use cases, but they should not be the final approval point for data use, code-assisted workflows, or exception handling.

This matters because GenAI in development is not just a productivity choice. It can change how source code, secrets, prompts, test data, and architecture decisions move through the pipeline. If approval sits too close to the end user, the organisation often gets inconsistency: one team permits a model because it is convenient, another blocks it because the data boundary is unclear, and neither has a consistent record of what was authorised. The safer model is a named owner for policy and risk acceptance, plus clear operational gatekeepers for implementation. For broader governance context, the NIST AI 600-1 GenAI Profile provides useful framing for managing GenAI risk in organisational settings.

In practice, many security teams discover weak GenAI approval boundaries only after a developer has already introduced an unreviewed workflow into source control or shared sensitive context with a model.

What approval needs to cover before developers can use GenAI?

Approval is not a single yes-or-no decision. It should define what type of use is allowed, what data may be provided, what outputs must be checked, and which parts of the workflow remain human-owned. A team may allow GenAI for drafting boilerplate, refactoring non-sensitive code, or summarising public documentation, while rejecting use for secrets, customer data, regulated content, or design decisions that require formal review.

The practical question is whether the GenAI use case changes the trust boundary of development. If a model can see proprietary code, dependency manifests, tickets, or incident details, then the approval process must address confidentiality, retention, and access logging. If it can generate code that is merged automatically, then the approval process must also cover review quality, test coverage, and the risk of normalising insecure patterns. NIST guidance on security and privacy controls is useful here because approval needs to tie back to control ownership, not just policy language. See NIST SP 800-53 Rev 5 Security and Privacy Controls for the control-design perspective.

• Define the approved use case, not just the approved tool.
• Classify what data may enter prompts, training sets, or connected agents.
• Require review for outputs that affect code, infrastructure, or security decisions.
• Record who can grant exceptions when the use case falls outside policy.

Where this guidance breaks down is in teams that treat all GenAI use as equal, because the approval model then becomes too coarse to control sensitive workflows.

When does the approval model need extra safeguards or escalation?

Tighter GenAI approval often improves control, but it also adds process overhead and can slow delivery, so organisations need to balance speed against the cost of unreviewed exposure. The biggest edge cases appear when GenAI moves from low-risk assistance into tasks that handle secrets, production code, regulated data, or autonomous actions in CI/CD.

There is also a governance difference between approved use and approved scope. A model may be acceptable for documentation, yet not acceptable for code generation inside a release pipeline. Similarly, a team may approve a tool for one repository but not for shared platform code, where mistakes can propagate broadly. This is where many organisations need an exception path, because blanket bans are usually bypassed, while blanket approvals are hard to defend. The useful rule is simple: the closer GenAI gets to production change, sensitive data, or irreversible action, the more explicit the owner, review chain, and escalation path need to be.

Where consensus is still limited is around how much assurance should be required for model outputs that are only advisory. Some teams treat advisory use as low risk; others require the same logging and data constraints as higher-impact use because developers tend to trust fluent output more than they should.

Practitioner Guidance

What to prioritise: Assign approval authority to the role that can enforce policy across code, data, and release decisions. If no one owns the full boundary, the approval process becomes symbolic and developers will make local decisions that are hard to reverse.

What to verify: Confirm that the approver can answer three questions without escalation: what data is allowed, what outputs require review, and when a use case must be stopped or reapproved. If those answers differ by team, the approval model is too fragmented to be reliable.

Decision rule: Treat any GenAI use that touches sensitive code, secrets, regulated data, or automated merge paths as a governance decision, not an individual productivity choice. That is the point where approval needs documented ownership and explicit risk acceptance.

Practitioner takeaway: The right approval owner is the person or function that can actually refuse, constrain, or revoke the use case when risk changes; without that power, accountability is only nominal.

Related resources from NHI Mgmt Group

• Who is accountable for keeping AI generated code compliant when development teams use autonomous coding workflows?
• Who is accountable for approving access when organizations use automated access review workflows?
• How should security teams use IAST and RASP in NHI governance?
• What makes GenAI usage part of the same secrets problem?